This difference comes from a difference in the cell cycle, accelerated in Mybpc3 and delayed in Lmna mutant mice, and presumably contributes to the phenotypic divergence of developing hypertrophic cardiomyopathy in patients with MYBPC3 mutation while developing DCM in those with LMNA mutation. This evidence concerns the gene LMNA and familial dilated cardiomyopathy.